Global Ready To Use Therapeutic Food Market Overview
Ready To Use Therapeutic Food Market Size was estimated at 11.54 (USD Billion) in 2022.The Ready To Use Therapeutic Food Industry is expected to grow from 12.53(USD Billion) in 2023 to 26.4 (USD Billion) by 2032. The Ready To Use Therapeutic Food Market CAGR (growth rate) is expected to be around 8.63% during the forecast period (2024 - 2032).
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Key Ready To Use Therapeutic Food Market Trends Highlighted
Increasing malnutrition rates in developing countries, particularly among children and pregnant women, are driving demand for ready-to-use therapeutic food (RUTF). RUTF's convenience and effectiveness in combating malnutrition have led to its widespread adoption by governments and humanitarian organizations. Moreover, rising awareness about the long-term consequences of malnutrition is fueling demand for preventive measures, such as the use of RUTF as a supplement.
Key market drivers include the expansion of nutrition programs in developing countries, government initiatives to address malnutrition, and the growing awareness of the importance of early nutrition. Opportunities lie in the development of new formulations and flavors to meet specific nutritional needs, as well as partnerships with local manufacturers to improve access in underserved areas.Recent trends include the integration of RUTF into community-based nutrition interventions, the development of lipid-based nutrient supplements (LNS) as an alternative to RUTF, and the increasing use of mobile technology to monitor and track malnutrition. These trends reflect the growing recognition of the need for holistic and sustainable approaches to addressing malnutrition.
Ready To Use Therapeutic Food Market Drivers
Rising Prevalence of Malnutrition and Hunger
There is a global pandemic of malnutrition and hunger, and in modern society, they must not be seen in any region. Ready-to-use therapeutic food is a food product that is given to aid in the recovery of severe acute malnutrition in children. The RUTF and supplementary therapeutic food have driven the global RUTF market. There is an increasing trend in malnutrition and hunger, which fuels the growth of RUTF due to the increased demand. World Health Organization states that there are about 45 million under-six children with SAM, and the number will continue to rise over the years due to poverty, insecurity of food, and conflict.
Increasing Awareness and Adoption of RUTF
One of the reasons driving the growth of the global RUTF market is the growing adoption and awareness of RUTF as an effective treatment for severe acute malnutrition. An increasing number of healthcare professionals, governments, and NGOs are beginning to acknowledge the benefits of RUTF for malnourished children through reducing mortality rates and improving their nutritional requirements. It is currently the first-line treatment for SAM, according to WHO, and many countries have formulated RUTF as part of their national guidelines.
Expanding Government and NGO Support
Governments and non-governmental organizations are the most active entities in developing countries that ensure the distribution and usage of RUTF. Governments have also been involved in a number of programs to provide RUTF support to children. The first such programs reached children after they implemented the RUTF initiative in their public health institutions and community programs. A significant number of child nutrition services have been supported by these programs.NGOs are also highly active in this field, providing products and nutritional services to vulnerable groups. The increasing support from governments and service providers sustains the global RUTF market
Ready To Use Therapeutic Food Market Segment Insights
Ready To Use Therapeutic Food Market Product Type Insights
Ready To Use Therapeutic Food Market By Product Type is Nutrient-Rich Foods, Antioxidant-Rich Foods, Prebiotic-Rich Foods, Probiotic-Rich Foods and Low-Glycemic Index Foods. Nutrient-Rich Foods Nutrient-rich food is a type of ready-to-use therapeutic food that is designed to provide essential nutrients for people who are suffering from malnutrition. Nutrient-rich foods are made from a blend of different types of ingredients that are rich in protein, carbohydrate and fats.
The global market for nutrient-rich food was valued at USD 1.5 billion in 2019 and is expected to reach USD 1.9 billion by 2020 and further expected to grow at a CAGR of 6.5% from 2020 to 2025.The growth in the market is being driven by an increasing prevalence of malnutrition in the developing countries. Antioxidant-Rich Foods Antioxidant-rich food is a type of RUTF that is designed to provide antioxidants for people who are suffering from oxidative stress. Oxidative stress is a condition that can damage the cells and can cause a number of chronic diseases. The global market for antioxidant-rich food was valued at USD 1.25 billion in 2019 and is expected to reach USD 1.5 billion by 2020 and further grow at a CAGR of 7.2% from 2020 to 2025.
The growth of the market is being driven by the rising awareness of the proven health benefits of antioxidants and the rising prevalence of chronic diseases. Prebiotic-Rich Foods Prebiotic-rich food is a type of RUTF that is designed to provide prebiotics for people who are suffering from health problems in the digestive system. Prebiotics are a form of fiber that cannot be digested by the human gut, so it becomes important to feed the good bacteria in the gut and improve the overall health of the gut system. Prebiotic-Rich Foods Prebiotic-rich foods are a type of RUTF that is formulated to provide prebiotics to people who are suffering from digestive problems.Prebiotics are a type of nondigestible food ingredient that can stimulate the growth and activity of some good bacteria in the gut.
The global market for prebiotic-rich foods is estimated to be worth USD 1 billion by 2025, growing at a CAGR of 7.5% from 2020 to 2025. The growth of this market is attributed to the rising prevalence of digestive problems and the increasing knowledge about the advantages of using prebiotics. Probiotic-Rich Foods Probiotic-rich foods are a type of RUTF that is made to provide probiotics to people who are suffering from digestive problems.Probiotics are a type of live bacteria that can assist in enhancing the well-being of the digestive system. The global market for probiotic-rich foods is expected to reach USD 1.3 billion by 2025, growing at a CAGR of 8% from 2020 to 2025.
The growth of the market for probiotic-rich foods is attributed to the rising prevalence of digestive problems and the increasing knowledge of the benefits of probiotics. Low-Glycemic Index Foods Low-glycemic index foods are a type of RUTF that is developed to provide a low and consistent supply of energy to people who are suffering from diabetes, obesity, or other blood sugar problems.The formulation of low-glycemic index foods usually contains a fusion of low sugar and low starch ingredients. The global market for low-glycemic index foods is expected to reach USD 1.4 billion by 2025, growing at a CAGR of 6.8% from 2020 to 2025. The growth of this market is attributed to the rising prevalence of diabetes and other blood sugar problems.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Ready To Use Therapeutic Food Market Target Population Insights
The Ready To Use Therapeutic Food Market segmentation by Target Population includes Children Under 5 Years, Pregnant and Lactating Women, HIV/AIDS Patients, Cancer Patients, and Elderly Population. Among these segments, Children Under 5 Years accounted for the largest market share in 2023, owing to the high prevalence of malnutrition and severe acute malnutrition among children in developing countries. The market for Ready To Use Therapeutic Food for Children Under 5 Years is expected to continue growing significantly in the coming years, driven by increasing awareness about malnutrition and the availability of government programs and initiatives to address it.Additionally, the increasing focus on preventive measures and early detection of malnutrition is expected to contribute to the growth of this segment
Ready To Use Therapeutic Food Market Distribution Channel Insights
The distribution channel segment plays a crucial role in the Ready To Use Therapeutic Food Market. In 2023, the Ready To Use Therapeutic Food Market was valued at 12.53 billion USD. Hospitals and clinics are the primary distribution channels for Ready To Use Therapeutic Food, accounting for a significant share of the market. In 2023, the market revenue generated through hospitals and clinics was approximately 6.5 billion USD. Pharmacies are another important distribution channel, facilitating the sale of Ready To Use Therapeutic Food.Supermarkets and hypermarkets are gaining popularity as distribution channels, offering convenience and accessibility to consumers. The market revenue through supermarkets and hypermarkets is projected to reach 2.5 billion USD by 2024. Online retailers are emerging as a growing distribution channel, leveraging the benefits of e-commerce. Non-governmental organizations play a vital role in distributing Ready To Use Therapeutic Food in regions with limited access to healthcare facilities.
Ready To Use Therapeutic Food Market End-Use Application Insights
The Ready To Use Therapeutic Food Market is segmented into Malnutrition Prevention, Malnutrition Treatment, Growth Promotion, Immune System Support, and Disease Prevention based on End-Use Application. In 2023, Malnutrition Treatment represented the largest segment of the market, accounting for nearly half of the Ready To Use Therapeutic Food Market revenue. This is due to the high prevalence of malnutrition in developing countries, where access to adequate nutrition is a major challenge. However, the Malnutrition Prevention segment is expected to experience significant growth over the forecast period as governments and organizations increasingly focus on preventing malnutrition rather than treating it.The Ready To Use Therapeutic Food Market segmentation data provides valuable insights into the different applications of Ready To Use Therapeutic Food, helping manufacturers and suppliers tailor their products and services to meet the specific needs of each segment.
Ready To Use Therapeutic Food Market Regional Insights
The regional segmentation of the Ready To Use Therapeutic Food Market provides insights into the market's geographic distribution and growth potential. North America is expected to hold a significant share of the market in 2023, owing to the presence of a large number of manufacturers and a high prevalence of malnutrition. Europe is another key market, driven by increasing awareness about the benefits of RUTF and government initiatives to combat malnutrition. The Asia-Pacific region is expected to witness the highest growth rate during the forecast period, driven by rising disposable income, improving healthcare infrastructure, and increasing awareness about the importance of nutrition.South America and the Middle East and Africa (MEA) are also expected to contribute to the growth of the global RUTF market, albeit at a slower pace compared to other regions
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
Ready To Use Therapeutic Food Market Key Players And Competitive Insights
Key players in the Ready To Use Therapeutic Food Market are paying strong attention to competitive product offerings to gain a foothold in market position. Moreover, other key trends include expansion of product portfolio, investment in research and development, and forming alliances with other market players. However, leaders of the respective industry are actively engaging in mergers and acquisitions to gain more market share and captive new markets. The market also has seen the presence of several new small and medium-scale companies willing to offer a wide array of innovative product lines.One of the competitive rivals is Nutriset, which is a France-based company offering specialization in providing and selling ready-to-use therapeutic foods.
The company is well positioned in developing companies where the products are sold to treat malnutrition of children. However, there are numerous ready-to-use therapeutic foods being offered to vulnerable people. Plumpy’Nut is one of the well-known ready-to-use therapeutic food products used to provide special nutritional values to vulnerable populations. Moreover, the company is highly engaged in the research and development field and has formed a collaboration with Bretana. It has a product range of ready-to-use therapeutic food, which also includes – Plumpy’Sup, another ready-to-use therapeutic food for particularly vulnerable women. In addition, the company's distribution presence in Lesotho and Madagascar produces ready-to-use therapeutic foods products in France and Niger, respectively.
Finally, Soy-based ready-to-use therapeutic food, which is another innovative ready-to-use therapeutic food from the company is – Plumpy’soy.Another competitive rival is DSM, which is a Dutch based company offering food and beverage business, and it also operates in multiple business fields. DSM offers RUTF or ready-to-use therapeutic food in the form of Nutrilon. RUTF is consumed in developed countries to treat malnutrition problems among infants and young children. The company is also engaged in the research and development field with its wide array of product lines. DSM’s product Nutrilon Forti.
Key Companies in the Ready To Use Therapeutic Food Market Include:
- Nutriset
- Concern Worldwide
- World Food Programme
- DSM
- UNICEF
- Danone
- CARE
- Edesia
- Action Against Hunger
- PlumpyField
- Save the Children
- World Vision
- Therapeutic Foods
- Nestle
- Meds Food for Kids
Ready To Use Therapeutic Food Market Industry Developments
The Ready-to-Use Therapeutic Food (RUTF) market is projected to grow significantly in the coming years due to rising malnutrition rates in developing countries, increasing awareness about the benefits of RUTF, and government initiatives to address malnutrition.Recent news developments in the market include the launch of new RUTF products by major manufacturers, such as Nutriset's Plumpy'Up and DSM's Supradyn. Additionally, several organizations are working to improve access to RUTF in underserved areas. For instance, the World Food Programme (WFP) has been implementing programs to distribute RUTF to malnourished children in conflict-affected and disaster-prone regions.Overall, the RUTF market is expected to witness steady growth in the coming years, driven by increasing demand from developing countries and ongoing efforts to address malnutrition globally.
Ready To Use Therapeutic Food Market Segmentation Insights
-
Ready To Use Therapeutic Food Market Product Type Outlook
- Nutrient-Rich Foods
- Antioxidant-Rich Foods
- Prebiotic-Rich Foods
- Probiotic-Rich Foods
- Low-Glycemic Index Foods
-
Ready To Use Therapeutic Food Market Target Population Outlook
- Children Under 5 Years
- Pregnant and Lactating Women
- HIV/AIDS Patients
- Cancer Patients
- Elderly Population
-
Ready To Use Therapeutic Food Market Distribution Channel Outlook
- Hospitals and Clinics
- Pharmacies
- Supermarkets and Hypermarkets
- Online Retailers
- Non-Governmental Organizations
-
Ready To Use Therapeutic Food Market End-Use Application Outlook
- Malnutrition Prevention
- Malnutrition Treatment
- Growth Promotion
- Immune System Support
- Disease Prevention
-
Ready To Use Therapeutic Food Market Regional Outlook
- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa
| Report Attribute/Metric |
Details |
| Market Size 2022 |
11.54 (USD Billion) |
| Market Size 2023 |
12.53 (USD Billion) |
| Market Size 2032 |
26.4 (USD Billion) |
| Compound Annual Growth Rate (CAGR) |
8.63% (2024 - 2032) |
| Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year |
2023 |
| Market Forecast Period |
2024 - 2032 |
| Historical Data |
2019 - 2023 |
| Market Forecast Units |
USD Billion |
| Key Companies Profiled |
Nutriset, Concern Worldwide, World Food Programme, DSM, UNICEF, Danone, CARE, Edesia, Action Against Hunger, PlumpyField, Save the Children, World Vision, Therapeutic Foods, Nestle, Meds Food for Kids |
| Segments Covered |
Product Type, Target Population, Distribution Channel, End-Use Application, Regional |
| Key Market Opportunities |
Increasing malnutrition rates in developing countries Growing awareness of the benefits of ready to use therapeutic food Expanding government initiatives to combat malnutrition Rising demand for convenient and affordable nutritional options Technological advancements in food processing and packaging |
| Key Market Dynamics |
Increasing prevalence of malnutrition Growing demand for fortified foods Government initiatives and support programs Technological advancements Expanding distribution channels |
| Countries Covered |
North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The global Ready-to-Use Therapeutic Food market is expected to reach a valuation of USD 26.4 billion by 2032, exhibiting a CAGR of 8.63% during the forecast period (2024-2032).
The Asia Pacific region is expected to dominate the Ready-to-Use Therapeutic Food market, accounting for a significant share of the global market. Countries such as India, China, and Bangladesh are key contributors to the regional market.
Ready-to-Use Therapeutic Food is primarily used for the treatment and prevention of malnutrition, particularly in children under the age of five, pregnant and lactating women, and people affected by emergencies or natural disasters.
Key competitors in the Ready-to-Use Therapeutic Food Market include Nutriset, DSM, Reckitt Benckiser, and Edesia. These companies hold a substantial market share and are actively involved in research and development to enhance their product offerings.
The increasing prevalence of malnutrition, particularly in developing countries, is a primary growth driver for the Ready-to-Use Therapeutic Food Market. Additionally, rising awareness about the importance of nutrition and the effectiveness of RUTF in addressing malnutrition contributes to market growth.
Challenges in the Ready-to-Use Therapeutic Food Market include supply chain disruptions, particularly in remote areas, and ensuring the affordability and accessibility of RUTF for those in need. Additionally, fluctuations in raw material prices can impact production costs and market dynamics.
Key trends in the Ready-to-Use Therapeutic Food Market include the development of specialized RUTF formulations tailored to specific nutritional needs, such as for infants and children with severe acute malnutrition. Additionally, there is a growing focus on improving the taste and acceptability of RUTF products to enhance compliance and acceptability.
The COVID-19 pandemic has had a significant impact on the Ready-to-Use Therapeutic Food Market, disrupting supply chains and affecting the delivery of RUTF to malnourished populations. However, the pandemic has also highlighted the critical role of RUTF in addressing malnutrition, leading to increased demand and efforts to ensure its availability.
The regulatory landscape for the Ready-to-Use Therapeutic Food Market varies across different countries and regions. Regulatory bodies such as the World Health Organization (WHO) and national food and drug administrations establish standards and guidelines for the production, distribution, and use of RUTF to ensure product quality and safety.
The future prospects for the Ready-to-Use Therapeutic Food Market are positive, with increasing demand driven by the rising prevalence of malnutrition and the growing recognition of the effectiveness of RUTF in addressing this issue. Ongoing research and development efforts are expected to lead to further advancements in RUTF formulations and delivery methods, contributing to improved nutritional outcomes and market growth.
